Boston, MA 03/21/2014 (wallstreetpr) – Sinovac Biotech Ltd. (NASDAQ:SVA) shares received a buy recommendation from Aegis in the research note issued Thursday. The stock is visibly starting to team with positive sentiments from analysts after it posted positive results in the recently reported quarter. Prior to the Aegis note, analysts at Morgan Stanley (NYSE:MS) upgraded their view and price target on the stock. They assigned “overweight” recommendation on the stock, up from “equal-weight” in the previous note. The analysts raised price target on the stock to $9, significantly up from the previous $6.50. These positive ratings adjustment came on the back of solid reporting by the company. Sinovac Biotech Ltd. (NASDAQ:SVA) reported earning $0.10 per share in the fourth quarter, beating the consensus estimate of -$0.01 per share. The previous session saw the shares closing at $8.07, up 17.13 percent.
Flamel Technologies S.A. (ADR) (NASDAQ:FLML) is breaching important psychological barriers in its stock price in the recent breakout. However, investors are seemingly not swayed by the all-positive trend in the stock. The consensus estimates revisions noted on the stock are moving on the wrong side, thus suggesting that analysts are becoming increasingly bearish on the stock. However, it is worth noting that this week has been particularly wonderful for the stock. It dismantled the 52-week high price that has been standing there and instead established a new price at $14.95. Shares of Flamel Technologies S.A. (ADR) (NASDAQ:FLML) gained 10.53 percent to $14.70 in the previous session, marking yet another day of active trading of massive amount of shares.
Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) was a mover Thursday, and among the Brazil stocks that gained on the day. The gain of most Brazil stocks has been linked to the political climate shaping up in the country. It is more of a case where investors bet a leadership with more favorable terms might be able to help the stocks exit their loss territories. In Brazil, the war against inflation has at best, only served to trim profit margins for the domestic companies. Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) for instance was enjoying good electricity rates, until the government set in and interfered with the power prices. Shares of the power utility company rose 2.42 percent to $4.23 in the previous session.
